Management of autoimmune disorders in patients with thymic epithelial tumors

We invite you to watch a recording of a webinar for patients and physicians prepared by The International Thymic Malignancy Interest Group (ITMIG) (itmig.org) on the occasion of the Thymic Malignancy Awareness Month (May).
The webinar took place on May 14, 2024.
Moderator: Dr. Chul Kim, Medical Oncologist
Speakers:
Dr. Henry Kaminski, Neurologist
Dr. Arun Rajan, Medical Oncologist
Dr. Dirk Van Raemdonck, Thoracic Surgeon

[@km70387]

Patient has myasthenia gravis AChR positive antibodies. Muscle biopsy shows neurogenic changes, some atrophy and lymphocytic infiltration, CD4, CD8, CD20. Confirmed not to be a true myostis. No thymic mass can be seen on scans, except for a small nodular shape of 1.5cm in thymus and suspected residual thymic tissue. Does this lymphocytic indication in the muscles come from the thymus and should it be removed?